3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
9
Neoplasms
5
Anxiety Disorders
5
Pain
3
Lung Neoplasms
3
Depression
3
Sleep Initiation and Maintenance Disorders
2
Polycystic Ovary Syndrome
2
Obesity
2
Neuropathy, Painful
2
Fatigue
2
Chronic Pain
2
Uterine Cervical Neoplasms
1
Stress, Psychological
1
Squamous Intraepithelial Lesions
1
Smoking
1
Signs and Symptoms
1
Sexual Dysfunction, Physiological
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Papillomavirus Infections
1
Overweight
1
Ovarian Neoplasms
1
Neurobehavioral Manifestations
1
Multiple Myeloma
1
Motor Activity
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma
1
Hot Flashes
1
Interventions
Morphine
7
Ketamine
5
Fentanyl
4
Sodium Chloride
3
Saline Solution
3
Lidocaine
3
Educational Status
3
Dexmedetomidine
3
Cognitive Behavioral Therapy
3
Anesthetics, Local
3
Surveys and Questionnaires
2
Pregabalin
2
Mindfulness-Based Stress Reduction
2
Hypnosis
2
Bupivacaine
2
Acetaminophen
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tianeptine
1
siltuximab
1
onabotulinum toxin A
1
nabiximols
1
morphine, naltrexone combination
1
erenumab
1
Yoga
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Tramadol
1
Therapeutics
1
Telemedicine
1
Tea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Chronic Pain
×
Mindfulness-Based Stress Reduction
×
Clear all
NCT02758197
2020-11-30
COMPASSION
Ottawa Hospital Research Institute
Phase NA
Completed
120 enrolled
NCT02125006
2019-07-23
InDepth
Ottawa Hospital Research Institute
Phase NA
Completed
118 enrolled